Trial
NCT02902744
Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Diabetic Macular Edema
Intervention
ILUVIEN®
Why stopped
The study was withdrawn due to difficult recruitment of patients for the study; No participants were enrolled in the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-22